A citation-based method for searching scientific literature

Siamak A Kamranvar, Maria G Masucci. Viruses 2017
Times Cited: 6







List of co-cited articles
15 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Epstein-Barr virus: 40 years on.
Lawrence S Young, Alan B Rickinson. Nat Rev Cancer 2004
50

EBNA2 and activated Notch induce expression of BATF.
Lisa M Johansen, Christopher D Deppmann, Kimberly D Erickson, William F Coffin, Tina M Thornton, Sean E Humphrey, Jennifer M Martin, Elizabeth J Taparowsky. J Virol 2003
36
33

Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity.
Lifang Yang, Zhijie Xu, Liyu Liu, Xiangjian Luo, Jingchen Lu, Lunquan Sun, Ya Cao. Cancer Biol Ther 2014
28
33

hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
Silvia Giunco, Riccardo Dolcetti, Sonia Keppel, Andrea Celeghin, Stefano Indraccolo, Jessica Dal Col, Katy Mastorci, Anita De Rossi. Clin Cancer Res 2013
19
33

hTERT inhibits the Epstein-Barr virus lytic cycle and promotes the proliferation of primary B lymphocytes: implications for EBV-driven lymphomagenesis.
Liliana Terrin, Riccardo Dolcetti, Irene Corradini, Stefano Indraccolo, Jessica Dal Col, Roberta Bertorelle, Laura Bonaldi, Giovanni Esposito, Anita De Rossi. Int J Cancer 2007
31
33

CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors.
Yijie Ma, Michael J Walsh, Katharina Bernhardt, Camille W Ashbaugh, Stephen J Trudeau, Isabelle Y Ashbaugh, Sizun Jiang, Chang Jiang, Bo Zhao, David E Root,[...]. Cell Host Microbe 2017
58
33

Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virus.
S Giunco, A Celeghin, K Gianesin, R Dolcetti, S Indraccolo, A De Rossi. Cell Death Dis 2015
16
33

Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cell lines.
A Mochida, E Gotoh, H Senpuku, S Harada, R Kitamura, T Takahashi, K Yanagi. Arch Virol 2005
19
33

Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Z Liu, Q Li, K Li, L Chen, W Li, M Hou, T Liu, J Yang, C Lindvall, M Björkholm,[...]. Oncogene 2013
173
33

Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.
Liliana Terrin, Jessica Dal Col, Enrica Rampazzo, Paola Zancai, Moreno Pedrotti, Grazia Ammirabile, Stefano Bergamin, Silvana Rizzo, Riccardo Dolcetti, Anita De Rossi. J Virol 2008
50
33


The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species.
Bettina Gruhne, Ramakrishna Sompallae, Diego Marescotti, Siamak Akbari Kamranvar, Stefano Gastaldello, Maria G Masucci. Proc Natl Acad Sci U S A 2009
161
33


Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia.
Marcia Bellon, Abhik Datta, Megan Brown, Jean-Francois Pouliquen, Pierre Couppie, Mirdad Kazanji, Christophe Nicot. Int J Cancer 2006
59
33

Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors.
Wen-hai Feng, Bruce Israel, Nancy Raab-Traub, Pierre Busson, Shannon C Kenney. Cancer Res 2002
126
16

Epstein-Barr virus-targeted therapy in nasopharyngeal carcinoma.
Sharon D Stoker, Zlata Novalić, Maarten A Wildeman, Alwin D R Huitema, Sandra A W M Verkuijlen, Hedy Juwana, Astrid E Greijer, I Bing Tan, Jaap M Middeldorp, Jan Paul de Boer. J Cancer Res Clin Oncol 2015
28
16

AZT as a telomerase inhibitor.
Daniel E Gomez, Romina G Armando, Daniel F Alonso. Front Oncol 2012
37
16

Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.
Wen-hai Feng, Jeffrey I Cohen, Steven Fischer, Li Li, Michael Sneller, Raphael Goldbach-Mansky, Nancy Raab-Traub, Henri-Jacques Delecluse, Shannon C Kenney. J Natl Cancer Inst 2004
170
16

Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas.
Riccardo Dolcetti, Jessica Dal Col, Debora Martorelli, Antonino Carbone, Eva Klein. Semin Cancer Biol 2013
43
16

A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.
Susan P Perrine, Olivier Hermine, Trudy Small, Felipe Suarez, Richard O'Reilly, Farid Boulad, Joyce Fingeroth, Melissa Askin, Arthur Levy, Steven J Mentzer,[...]. Blood 2007
170
16

Separation of telomerase functions by reverse genetics.
Shibani Mukherjee, Eduardo J Firpo, Yang Wang, James M Roberts. Proc Natl Acad Sci U S A 2011
64
16

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
16

Zidovudine-based lytic-inducing chemotherapy for Epstein-Barr virus-related lymphomas.
Ulas Darda Bayraktar, Luis A Diaz, Brittany Ashlock, Ngoc Toomey, Lisa Cabral, Soley Bayraktar, Denise Pereira, Dirk P Dittmer, Juan Carlos Ramos. Leuk Lymphoma 2014
12
16

Telomerase activity impacts on Epstein-Barr virus infection of AGS cells.
Jürgen Rac, Florian Haas, Andrina Schumacher, Jaap M Middeldorp, Henri-Jacques Delecluse, Roberto F Speck, Michele Bernasconi, David Nadal. PLoS One 2015
4
25

Epstein-Barr virus latent genes.
Myung-Soo Kang, Elliott Kieff. Exp Mol Med 2015
140
16

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.
De-Xue Fu, Yvette Tanhehco, Jianmeng Chen, Catherine A Foss, James J Fox, Ja-Mun Chong, Robert F Hobbs, Masashi Fukayama, George Sgouros, Jeanne Kowalski,[...]. Nat Med 2008
68
16

Overexpression of human telomerase reverse transcriptase promotes the motility and invasiveness of HepG2 cells in vitro.
Peng-Cheng Chen, Ji-Run Peng, Lei Huang, Wen-Xia Li, Wen-Zhen Wang, Zhu-Qing-Qing Cui, Hui Han, Lei Gong, Da-Peng Xiang, Shi-Shi Qiao,[...]. Oncol Rep 2013
15
16

Reactivation of telomerase in cancer.
Semih Can Akincilar, Bilal Unal, Vinay Tergaonkar. Cell Mol Life Sci 2016
80
16

Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology.
Annunziata Gloghini, Riccardo Dolcetti, Antonino Carbone. Semin Cancer Biol 2013
65
16

Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma.
Motoki Kurokawa, Subrata K Ghosh, Juan Carlos Ramos, Abdul M Mian, Ngoc L Toomey, Lisa Cabral, Denise Whitby, Glen N Barber, Dirk P Dittmer, William J Harrington. Blood 2005
40
16

Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells.
Andrea Celeghin, Silvia Giunco, Riccardo Freguja, Manuela Zangrossi, Silvia Nalio, Riccardo Dolcetti, Anita De Rossi. Cell Death Dis 2016
19
16

Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
Masanobu Sugimoto, Hidetoshi Tahara, Toshinori Ide, Yasuhiro Furuichi. Cancer Res 2004
110
16

siRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telomerase activity and expression.
Yu-Ping Mei, Xiao-Feng Zhu, Jun-Min Zhou, He Huang, Rong Deng, Yi-Xin Zeng. Cancer Lett 2006
35
16

Potent Human Telomerase Inhibitors: Molecular Dynamic Simulations, Multiple Pharmacophore-Based Virtual Screening, and Biochemical Assays.
Faezeh Shirgahi Talari, Kowsar Bagherzadeh, Sahand Golestanian, Michael Jarstfer, Massoud Amanlou. J Chem Inf Model 2015
13
16

Promiscuous expression of Epstein-Barr virus genes in Burkitt's lymphoma from the central African country Malawi.
Shao-an Xue, Louise G Labrecque, Qi-Long Lu, S Kate Ong, Irvin A Lampert, Peter Kazembe, Elizabeth Molyneux, Robin L Broadhead, Eric Borgstein, Beverly E Griffin. Int J Cancer 2002
78
16

TERT promoter mutations in telomere biology.
Barbara Heidenreich, Rajiv Kumar. Mutat Res Rev Mutat Res 2017
76
16

Cytolytic virus activation therapy for Epstein-Barr virus-driven tumors.
Maarten A Wildeman, Zlata Novalic, Sandra A W M Verkuijlen, Hedy Juwana, Alwin D R Huitema, I Bing Tan, Jaap M Middeldorp, Jan Paul de Boer, Astrid E Greijer. Clin Cancer Res 2012
47
16


Alternative Splicing of hTERT Pre-mRNA: A Potential Strategy for the Regulation of Telomerase Activity.
Xuewen Liu, Yuchuan Wang, Guangming Chang, Feng Wang, Fei Wang, Xin Geng. Int J Mol Sci 2017
19
16

Combined introduction of Bmi-1 and hTERT immortalizes human adipose tissue-derived stromal cells with low risk of transformation.
Péter Tátrai, Áron Szepesi, Zsolt Matula, Anna Szigeti, Gyöngyi Buchan, András Mádi, Ferenc Uher, Katalin Német. Biochem Biophys Res Commun 2012
27
16

Chromosomal rearrangements after ex vivo Epstein-Barr virus (EBV) infection of human B cells.
S Lacoste, E Wiechec, A G Dos Santos Silva, A Guffei, G Williams, M Lowbeer, K Benedek, M Henriksson, G Klein, S Mai. Oncogene 2010
52
16

Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging.
Elizabeth H Blackburn, Carol W Greider, Jack W Szostak. Nat Med 2006
562
16

Regulation of the latent-lytic switch in Epstein-Barr virus.
Shannon C Kenney, Janet E Mertz. Semin Cancer Biol 2014
139
16


Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment.
Ayumi Kudoh, Masatoshi Fujita, Lumin Zhang, Noriko Shirata, Tohru Daikoku, Yutaka Sugaya, Hiroki Isomura, Yukihiro Nishiyama, Tatsuya Tsurumi. J Biol Chem 2005
141
16

Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease.
K T Montone, R L Hodinka, K E Salhany, E Lavi, A Rostami, J E Tomaszewski. Mod Pathol 1996
52
16

Latent Epstein-Barr virus can inhibit apoptosis in B cells by blocking the induction of NOXA expression.
Jade Yee, Robert E White, Emma Anderton, Martin J Allday. PLoS One 2011
20
16

Telomeres shorten during ageing of human fibroblasts.
C B Harley, A B Futcher, C W Greider. Nature 1990
16



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.